COPD activates bitter taste receptors, the target of asthma treatment

Published Date: 17 Mar 2023

Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...

Read Full News

Latest News

Innovations in NSCLC: Outlooks on Clinical Trials and Emerging Bispecific ADCs

Innovations in NSCLC: Outlooks on Clinical Trials and Emerging Bispecific ADCs

My Job Has Become Mounds of Paperwork. Work Requirements Will Make it Worse.

The new Medicaid rule is unworkable

FDA Says Juul Can Sell Updated Vaping Device With Age-Gating Technology

Agency allows company to sell a new version of its top-selling device

FDA Approves Four Updated COVID Shots Targeting XFG Variant

Approvals come as the CDC's vaccine advisory panel remains in legal limbo

Doctors Groups Offer Updated Flu, COVID Vaccine Recs to Ease Confusion

AMA, AAFP, IDSA, and others are issuing the guidelines and highlighting the science behind them

Docs Alarmed by NIH Plan to Redirect Medical Research $$ to Pentagon

Few details are available on the proposal, which has a 5-day comment period

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Latest News

Innovations in NSCLC: Outlooks on Clinical Trials and Emerging Bispecific ADCs

The new Medicaid rule is unworkable

Agency allows company to sell a new version of its top-selling device

Approvals come as the CDC's vaccine advisory panel remains in legal limbo

AMA, AAFP, IDSA, and others are issuing the guidelines and highlighting the science behind them

Few details are available on the proposal, which has a 5-day comment period

News All Time

US CDC Records More Than 3,100 Measles Cases So Far in 2026

The U.S. Centers for Disease Control and Prevention said on Friday there were 3,134 confirmed measles ⁠cases in the country so far this year, marking the highest annual...

Holistic Care Must Be Standard in Lung Disease

Experts at ERS 2026 urge clinicians to treat the whole person rather than just damaged lungs, moving from mere symptom control to focus on what matters most to each patient.

CPAP May Offer Enhanced BP Benefit in Sleep Apnea & Insomnia

Patients with both insomnia and obstructive sleep apnea may represent a clinical phenotype characterized by an enhanced systolic BP-lowering response to continuous positive airway pressure therapy.

Australia Confirms First H5N1 Bird Flu Case in Local Mammal

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast Lowers Mortality Risk in Pulmonary Fibrosis

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

New GLP-1 Concern; FDA Sued by Health Groups; Over 750 Dead in Ebola Outbreak

Health news and commentary gathered by MedPage Today staff

Wildfires Expose Millions in the Midwest and Northeast U.S. to Dangerous Smoke

States warned residents about air quality issues that could last for days

Nerve Stimulation for Sleep Apnea Linked to Some Long-Term Heart Benefits

But the higher risk of hypertension and cardiovascular events within 2 years was unexpected

Wildfire Smoke Kills Tens of Thousands Each Year. Here's How It Attacks the Body.

"It's a big giant toxic soup of particles and gases," expert says

Novel Antifungal Shows Activity in Valley Fever

Three-quarters of patients had a clinical response in mid-stage study

Reproductive Health Should Be Emphasized in Cystic Fibrosis Care, Foundation Says

Clinicians should initiate annual discussions

FDA Greenlights Next-Generation ROS1 Inhibitor for Lung Cancer

Zidesamtinib is indicated for patients who received a prior ROS1 inhibitor

CDC Suggests Threat of Mold-Associated Illnesses May Be Underappreciated

"It's kind of the first time we've had an estimate like this," the study's senior author says

Recommended News For You

Opposition to the Surgical Lymph Node Sampling Rule for Lung Resection.

Early PET May Help Tailor Therapy in Hodgkin Lymphoma

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

Medical debt in collections persists after cancer diagnosis

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

Independent Risk Factors for "Deaths of Despair" Found.

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.

Recommended Articles For You

Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care 

Acrochordon: What It Is, Causes, And How To Manage This Skin Condition 

Drug Safety Through Oncology Survivorship Medication Monitoring Frameworks 

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

It Is Not Just the Royals Who Go Through Cancer.

2.

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study

3.

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

4.

Annual whole-body, low-dose CT aids management of smoldering multiple myeloma

5.

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

1.

Tumor Microenvironment Reprogramming for Regenerative Cancer Recovery

2.

A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer

3.

Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management

4.

Exercise Rehabilitation in Hematologic Disease Survivorship

5.

Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

2.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

3.

Navigating the Complexities of Ph Negative ALL - Part VIII

4.

Current Scenario of Cancer- Q&A Session to Close the Gap

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot